Zobrazeno 1 - 10
of 480
pro vyhledávání: '"Kathy D Miller"'
Autor:
Laura Q Rogers, Stephen J Carter, Marissa N Baranauskas, Tarah J Ballinger, Kathy D Miller, Dustin C Nabhan
Publikováno v:
BMJ Open Sport & Exercise Medicine, Vol 7, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/864ac99f244949f3888f4918f8e8db9e
Autor:
Olga Kim, Eun Young Park, David L Klinkebiel, Svetlana D Pack, Yong-Hyun Shin, Zied Abdullaev, Robert E Emerson, Donna M Coffey, Sun Young Kwon, Chad J Creighton, Sanghoon Kwon, Edmund C Chang, Theodore Chiang, Alexander N Yatsenko, Jeremy Chien, Dong-Joo Cheon, Yang Yang-Hartwich, Harikrishna Nakshatri, Kenneth P Nephew, Richard R Behringer, Facundo M Fernández, Chi-Heum Cho, Barbara Vanderhyden, Ronny Drapkin, Robert C Bast, Kathy D Miller, Adam R Karpf, Jaeyeon Kim
Publikováno v:
PLoS Genetics, Vol 16, Iss 6, p e1008808 (2020)
Metastasis is responsible for 90% of human cancer mortality, yet it remains a challenge to model human cancer metastasis in vivo. Here we describe mouse models of high-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), the
Externí odkaz:
https://doaj.org/article/a0866ddae28348acb288e0a6cd580d54
Autor:
Fei Shen, Guanglong Jiang, Santosh Philips, Laura Gardner, Gloria Xue, Erica Cantor, Reynold C. Ly, Wilberforce Osei, Xi Wu, Chau Dang, Donald Northfelt, Todd Skaar, Kathy D. Miller, George W. Sledge, Bryan P. Schneider
Publikováno v:
Clinical Cancer Research. :OF1-OF7
Purpose: Paclitaxel is a widely used anticancer therapeutic. Peripheral neuropathy is the dose-limiting toxicity and negatively impacts quality of life. Rare germline gene markers were evaluated for predicting severe taxane-induced peripheral neuropa
Autor:
Aditi S. Khatpe, Rebecca Dirks, Poornima Bhat-Nakshatri, Henry Mang, Katie Batic, Sarah Swiezy, Jacob Olson, Xi Rao, Yue Wang, Hiromi Tanaka, Sheng Liu, Jun Wan, Duojiao Chen, Yunlong Liu, Fang Fang, Sandra Althouse, Emily Hulsey, Maggie M. Granatir, Rebekah Addison, Constance J. Temm, George Sandusky, Audrey Lee-Gosselin, Kenneth Nephew, Kathy D. Miller, Harikrishna Nakshatri
Publikováno v:
Cancer Research. 83:1345-1360
Study of genomic aberrations leading to immortalization of epithelial cells has been technically challenging due to the lack of isogenic models. To address this, we used healthy primary breast luminal epithelial cells of different genetic ancestry an
Autor:
Amelia B. Zelnak, Heinz-Josef Lenz, Kerry Culm, Lukas Makris, Valerie Chamberlain Santos, Hagop Youssoufian, Colleen Mockbee, Kathy D. Miller
Publikováno v:
Cancer Research. 83:OT2-16
Objective: The objective of this Phase 2, open-label, multicenter study is to investigate the antitumor activity of navicixizumab monotherapy or in combination with chemotherapy in patients with advanced solid tumors. Cohort C will enroll triple-nega
Autor:
Erica L. Mayer, Yue Ren, Nikhil Wagle, Reshma Mahtani, Cynthia Ma, Angela DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D. Miller, Trevor Jolly, Elizabeth Riley, Rubina Qamar, Priyanka Sharma, Sonya Reid, Natalie Sinclair, Meredith Faggen, Caroline Block, Naomi Ko, Ann Partridge, Wendy Y. Chen, Michelle K. DeMeo, Victoria Attaya, Amanda Okpoebo, Yuan Liu, Eric Gauthier, Harold Burstein, Meredith Regan, Sara Tolaney
Publikováno v:
Cancer Research. 83:GS3-06
Background CDK4/6 inhibitors (CDK4/6i) in combination with endocrine therapy (ET) have a well-established role in the management of hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC). The benefit of continuing CDK4/6i beyond progres
Autor:
Tarah J. Ballinger, Gloria Xue, Helga S. Marques, Constantine Gatsonis, Richard Hoffman, Kathy D. Miller, Fengmin Zhao, Joseph Sparano, Roisin Connolly
Publikováno v:
Cancer Research. 83:P3-05
Introduction: Observational data investigating the relationship between body habitus and survival or toxicity in breast cancer has been largely centered in the curative setting and focused on weight- based metrics, with variable and inconsistent resu
Autor:
Veda N. Giri, Thomas K. Oliver, R. Bryan Rumble, Jonathan W. Friedberg, Kathy D. Miller, Rachel L. Geisel
Publikováno v:
Journal of Clinical Oncology. 41:955-957
Autor:
Bryan P. Schneider, George W. Sledge, Kathy D. Miller, Todd Skaar, Donald Northfelt, Chau Dang, Xi Wu, Wilberforce Osei, Reynold C. Ly, Erica Cantor, Gloria Xue, Laura Gardner, Santosh Philips, Guanglong Jiang, Fei Shen
Purpose:Paclitaxel is a widely used anticancer therapeutic. Peripheral neuropathy is the dose-limiting toxicity and negatively impacts quality of life. Rare germline gene markers were evaluated for predicting severe taxane-induced peripheral neuropat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e32715bb356b62470124f00702cc1d
https://doi.org/10.1158/1078-0432.c.6651161
https://doi.org/10.1158/1078-0432.c.6651161
Autor:
Bryan P. Schneider, George W. Sledge, Kathy D. Miller, Todd Skaar, Donald Northfelt, Chau Dang, Xi Wu, Wilberforce Osei, Reynold C. Ly, Erica Cantor, Gloria Xue, Laura Gardner, Santosh Philips, Guanglong Jiang, Fei Shen
Supplemental table 1-Covariates analyses; Supplemental Table 2-Genotype frequency, variant allele frequency and Hardy-Weinberg Equilibrium (HWE) of variants in CYPs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01793e40cbd1fa4cb9d70e9bbe42c588
https://doi.org/10.1158/1078-0432.22893692.v1
https://doi.org/10.1158/1078-0432.22893692.v1